Impact of potent nucleos(t)ide therapy on hepatitis B hospitalisations in Spain.
José-Manuel Ramos-RinconHéctor Pinargote-CelorioCarmen de MendozaClara Ramos-BelinchónPablo BarreiroAna TreviñoOctavio CorralVicente SorianoPublished in: Alimentary pharmacology & therapeutics (2022)
Hospital admissions of individuals with HBV infection are increasing in Spain. While hepatic decompensation events declined following the introduction of potent oral nucleos(t)ide therapy, HBV-related liver cancer is rising. No benefit of oral antiviral therapies is seen on hepatitis delta.